lobbying_activities: 1517297

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1517297	e4cb23fb-a0a2-4e30-8dec-d1eef651fa62	Q1	CAPITOL HILL CONSULTING GROUP	72053	WELLNESS PHARMACY	2014	first_quarter	PHA	Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act	HOUSE OF REPRESENTATIVES,SENATE	10000		0	0	2014-04-15T16:54:33.480000-04:00